Cytosorbents
CTSO
#10589
Rank
A$35.56 M
Marketcap
A$0.57
Share price
3.61%
Change (1 day)
-58.96%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -A$18.07 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$37.2 Million. In 2025 the company made an earning of -A$12.22 Million, an increase over its 2024 earnings that were of -A$32.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$18.07 Million47.9%
2025 -A$12.22 Million-62.16%
2024 -A$32.27 Million-22.49%
2023 -A$41.64 Million-13.52%
2022 -A$48.15 Million34.04%
2021 -A$35.92 Million182.17%
2020 -A$12.73 Million-55.97%
2019 -A$28.91 Million14.17%
2018 -A$25.32 Million95.14%
2017 -A$12.98 Million-22.32%
2016 -A$16.71 Million39.1%
2015 -A$12.01 Million-12.89%
2014 -A$13.79 Million89%
2013 -A$7.3 Million26.65%
2012 -A$5.76 Million-26.02%
2011 -A$7.79 Million-288.45%
2010 A$4.13 M-4.17%
2009 A$4.31 M-287.19%
2008 -A$2.31 Million-47.12%
2007 -A$4.36 Million41.78%
2006 -A$3.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.31 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.10 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$78.81 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA